This rapid increase in prescription rates followed the recent approval of two GLP-1R agonists, semaglutide (Ozempic, Wegovy) and liraglutide (Victoza), for weight management in obese or overweight patients
Cobenfy takes treatment of schizophrenia in a totally new direction for the first time in decades
PubMed evidence trail Research sources used to frame this page For Retatrutide and Thyroid: Side Effects, Risks and How to Manage (2026), FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available
D., Carlucci, L., Zentilin, L., Secco, I., et al